Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics. Hence, determination of mutations in k-ras gene is crucial...
Saved in:
Main Authors: | Nazanin Bagherlou (Author), Safar Farajnia (Author), Saber Zahri (Author), Ali Dastranj Tabrizi (Author), Atefeh Nazari (Author) |
---|---|
Format: | Book |
Published: |
Babol University of Medical Sciences,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIAGNOSTIC VALUE OF TUMOR MARKER CA-125 IN THE EARLY DIAGNOSIS OF OVARIAN CANCER
by: Светлана Ивановна Елгина, et al.
Published: (2020) -
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder
by: Manoj K Bind, et al.
Published: (2021) -
Correlation of ovarian fibroma with elevated serum CA-125
by: Wing-Yuk Chan, et al.
Published: (2014) -
Mesothelin versus Ca125 in Screening the Ovarian Malignancy
by: Meliana Jayasaputra, et al.
Published: (2016) -
Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125
by: Szu-Ting Yang, et al.
Published: (2023)